CHS is characterized by severe and persistent vomiting lasting for hours or days, chronic nausea that worsens with cannabis use, abdominal cramping, and temporary symptom relief from hot showers or baths. Younger individuals are also disproportionately affected compared to middle-aged or older adults.
Association of Multimodal Cannabis Use with Adverse Events among Adolescents and Young Adults.
The ways cannabis is consumed, or modes of use, have increased and diversified in recent years, especially among young people. Associations of multimodal can…
Medically Recommended Cannabis Use for US Adolescents.
As more states legalize medical cannabis, there is growing interest in its use in adolescents. This nationally-representative study assesses the prevalence o…
Endocannabinoid System Research: Clinical Evidence
Clinical Takeaway Clinical Takeaway: Adolescents who initially resist cannabis prevention messages show better engagement and reduced use when prevention programs address their specific objections with targeted rebuttals before presenting additional information. Tailoring...
Endocannabinoid System Clinical Research Guide
Clinical Takeaway Adolescents reporting depression, generalized anxiety, social anxiety, or panic symptoms at baseline showed increased risk for initiating cannabis use and greater frequency of use 18 months later, suggesting internalizing symptoms...
Endocannabinoid System and Anxiety Cannabis Research
Clinical Takeaway Clinical Takeaway: Adolescents experiencing depression and anxiety symptoms demonstrate increased risk for cannabis initiation and escalated use patterns, suggesting these psychiatric conditions represent a genuine vulnerability pathway rather than coincidental...
Endocannabinoid System: Anxiety, Depression and Cannabis Use
Clinical Takeaway Adolescents with depression and anxiety symptoms show increased cannabis use over 18 months, suggesting self-medication behavior in vulnerable populations. This longitudinal evidence indicates that mental health screening and early intervention...
Endocannabinoid System Research: Cannabis Use in Teen Anxiety
Clinical Takeaway Adolescents experiencing depression, generalized anxiety, social anxiety, or panic symptoms are more likely to initiate and increase cannabis use over time, suggesting these internalizing conditions may drive substance use as...
Most European Countries Lack Evidence-Based Cannabis-Specific Treatment
Sixteen countries reported the existence of specific cannabis-specific programs. Fifteen countries provided specific face-to-face interventions, which mostly have limited national coverage. Most programs are not evidence-based.
Selective Personality-Targeted Intervention and the Escalation of Substance Use During Adolescence: A Secondary Analysis of A Cluster-Randomized Clinical Trial.
Substance use is a leading cause of burden of disease worldwide. Selective prevention programs can help reduce the development of problematic substance use a…